Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tandem Mass Spectrometry01:21

Tandem Mass Spectrometry

2.7K
Tandem mass spectrometry is a technique that uses multiple mass analyzers in series to obtain a higher selectivity and reduce chemical noise during analyte detection. Instruments with multiple analyzers separated by an interaction cell enable secondary fragmentation and selected study of the fragment ions.Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called...
2.7K
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

8.7K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
8.7K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

678
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
678

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Nature communications·2026
Same author

Central venous access device-associated complication costs in paediatric cancer care.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Editorial for the Special Issue "Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis".

Pharmaceutics·2026
Same author

Picolinamide-functionalized macrocyclic chelators for <sup>203/212</sup>Pb theranostic radiotracers.

Inorganic chemistry frontiers·2026
Same author

Imaging xCT with Immuno-PET in Therapy-Resistant Non-Small Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Nurses' Clinical Decision-Making During Peripherally Inserted Central Catheter Dressing Application and Removal: A Qualitative Study.

Seminars in oncology nursing·2026

Related Experiment Video

Updated: Feb 28, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.6K

From [99mTc]pertechnetate to [99mTc]sestamibi: Dissection of a Complex Reaction Sequence Using Radio-LC-MS.

Joana do Mar Ferreira Machado1, Antonio Shegani1, Ingebjørg N Hungnes1

  • 1School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, 4th Floor Lambeth Wing, London SE1 7EH, UK.

Molecules (Basel, Switzerland)
|February 27, 2026
PubMed
Summary

The synthesis of technetium-99m-sestamibi (MIBI) involves complex redox and ligand exchange reactions. This study elucidates the reaction pathway, identifying key technetium intermediates for improved quality control in myocardial perfusion imaging.

Keywords:
LC-MSMIBImass spectrometrymethoxyisobutylisonitrileradiopharmaceuticalsestamibitechnetium

More Related Videos

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
17:12

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS

Published on: December 20, 2010

16.1K
Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

2.0K

Related Experiment Videos

Last Updated: Feb 28, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.6K
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
17:12

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS

Published on: December 20, 2010

16.1K
Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

2.0K

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Analytical Chemistry

Background:

  • [99mTc]sestamibi (MIBI) is a crucial SPECT tracer for myocardial perfusion imaging.
  • Its synthesis from [99mTc]pertechnetate involves complex oxidation state changes and ligand replacement.

Purpose of the Study:

  • To unravel the intricate reaction mechanism of [99mTc]sestamibi synthesis.
  • To inform rational quality control strategies for this diagnostic agent.
  • To identify novel technetium synthons for molecular imaging applications.

Main Methods:

  • Utilized generator-produced [99mTc]pertechnetate with commercial/bespoke kits.
  • Varied reaction parameters: time, temperature, reagent concentrations, and carrier technetium-99.
  • Analyzed radioactive products using TLC and HPLC with optical, radiometric, and MS-ESI+ detection.

Main Results:

  • Identified at least 11 radioactive intermediates via radio-HPLC.
  • Characterized technetium(V) and technetium(I) intermediates, including [TcVO(cysteinate)2]+ and [TcI(MIBI)5L1]+.
  • Indicated Tc(III) intermediates like [TcIII(cysteinate)2(MIBI)2]+ via MS-ESI+.

Conclusions:

  • The reaction proceeds from Tc(VII) through Tc(V) and Tc(III) intermediates to Tc(I).
  • The pathway involves sequential reduction and ligand exchange, culminating in the stable [Tc(MIBI)6]+ complex.
  • Understanding this mechanism aids in optimizing synthesis and quality control for myocardial perfusion SPECT imaging.